News center
Press release
Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement with AstraZeneca
Agreement includes license for Owkin’s AI Scientist, K Pro, for three years.
May 13, 2026
Press release
Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement with AstraZeneca
Agreement includes license for Owkin’s AI Scientist, K Pro, for three years.
May 13, 2026
Explore
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
In the media
AstraZeneca pens agentic AI licensing deal with Owkin
May 13, 2026
AstraZeneca pens agentic AI licensing deal with Owkin
May 13, 2026
Fierce Biotech
Press release
Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement with AstraZeneca
May 13, 2026
Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement with AstraZeneca
May 13, 2026
In the media
Business Next features Owkin about accelerating drug discovery
April 15, 2026
Business Next features Owkin about accelerating drug discovery
April 15, 2026
Business Next
Press release
Owkin creates new spin out Waiv, formerly Owkin Dx, with $33m financing
March 12, 2026
Owkin creates new spin out Waiv, formerly Owkin Dx, with $33m financing
March 12, 2026
Press release
Owkin Announces Partnership with Consensus to Strengthen Literature Intelligence for Owkin’s AI Scientist, K Pro
March 4, 2026
Owkin Announces Partnership with Consensus to Strengthen Literature Intelligence for Owkin’s AI Scientist, K Pro
March 4, 2026
Press release
NHS Lothian joins Owkin’s patient data network with multi-year partnership
March 3, 2026
NHS Lothian joins Owkin’s patient data network with multi-year partnership
March 3, 2026
Press release
Global AI Impact Summit 2026, India: Owkin strengthens its strategic partnerships with India to advance biological artificial super intelligence
February 18, 2026
Global AI Impact Summit 2026, India: Owkin strengthens its strategic partnerships with India to advance biological artificial super intelligence
February 18, 2026
Press release
Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences
January 12, 2026
Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences
January 12, 2026
Press release
Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs
January 12, 2026
Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs
January 12, 2026
Press release
Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA
January 12, 2026
Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA
January 12, 2026